quinoxalines has been researched along with dihydro-beta-erythroidine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 8 (42.11) | 29.6817 |
2010's | 10 (52.63) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Roberts, A; Wolf, E; Zhao, FY | 1 |
Wong, RO; Wong, WT | 1 |
Cherubini, E; Maggi, L; Sher, E | 1 |
Jeong, MS; Kim, CJ; Kim, KW; Park, EY; Park, JW; Shin, BS; Shin, MS; Woo, RS; Zhao, RJ | 1 |
Chiappinelli, VA; Guo, JZ; Liu, Y; Sorenson, EM | 1 |
Hamaue, N; Jia, Y; Sumikawa, K; Yamazaki, Y | 1 |
Decker, MW; Man, K; Parikh, V; Sarter, M | 1 |
Good, CH; Lupica, CR | 1 |
Blankenship, AG; Copenhagen, DR; Edwards, RH; Feller, MB; Ford, KJ; Johnson, J; Seal, RP | 1 |
Papke, RL; Stitzel, JA; Wecker, L | 1 |
Li, WC; Roberts, A; Soffe, SR | 1 |
Cunningham, CS; McMahon, LR | 2 |
Brooks, EA; Jutkiewicz, EM; Kynaston, AD; Rice, KC; Woods, JH | 1 |
Bell, KA; Chen, CK; McQuiston, AR; Shim, H | 1 |
Camarasa, J; Ciudad-Roberts, A; Escubedo, E; Pubill, D | 1 |
Bloem, B; Mansvelder, HD; Poorthuis, RB; Verhoog, MB | 1 |
Asaoka, N; Kaneko, S; Nagayasu, K; Nakagawa, T; Nishitani, N; Shirakawa, H; Yamashiro, M | 1 |
Kato, T; Kawano, T; Sato, H; Toyoda, H; Yin, DX | 1 |
19 other study(ies) available for quinoxalines and dihydro-beta-erythroidine
Article | Year |
---|---|
Longitudinal distribution of components of excitatory synaptic input to motoneurones during swimming in young Xenopus tadpoles: experiments with antagonists.
Topics: Animals; Cadmium; Convulsants; Dihydro-beta-Erythroidine; Electric Conductivity; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Kynurenic Acid; Larva; Motor Neurons; Quinoxalines; Receptors, Nicotinic; Spinal Cord; Strychnine; Swimming; Synapses; Xenopus | 1998 |
Changing specificity of neurotransmitter regulation of rapid dendritic remodeling during synaptogenesis.
Topics: Acetylcholine; Animals; Bacterial Proteins; Cell Movement; Chick Embryo; Dendrites; Dihydro-beta-Erythroidine; Excitatory Amino Acid Antagonists; Glutamic Acid; Luminescent Proteins; Microscopy, Confocal; Quinoxalines; Retinal Ganglion Cells; Synapses; Synaptic Transmission; Time Factors; Transfection | 2001 |
Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus.
Topics: Acetylcholine; Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Newborn; Bicuculline; Bridged-Ring Compounds; Dihydro-beta-Erythroidine; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Insecticides; Membrane Potentials; Nicotine; Nicotinic Agonists; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Quinoxalines; Rats; Rats, Wistar; Receptors, Nicotinic; Spiro Compounds | 2001 |
Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices.
Topics: Adolescent; Adult; Arginine; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Ganglionic Stimulants; Guanylate Cyclase; Humans; In Vitro Techniques; Indazoles; Male; Mecamylamine; Methylene Blue; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Antagonists; Nitrendipine; Nitric Oxide Synthase; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Purinones; Quinoxalines; Tetrodotoxin; Tritium; Tubocurarine | 2002 |
Synaptically released and exogenous ACh activates different nicotinic receptors to enhance evoked glutamatergic transmission in the lateral geniculate nucleus.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Aconitine; Analysis of Variance; Animals; Bicuculline; Bungarotoxins; Calcium; Calcium Channel Blockers; Chick Embryo; Conotoxins; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Evoked Potentials; Excitatory Amino Acid Antagonists; GABA Antagonists; Geniculate Bodies; Glutamic Acid; In Vitro Techniques; Magnesium; Membrane Potentials; Neurons; Nicotinic Antagonists; Patch-Clamp Techniques; Quinoxalines; Receptors, Nicotinic; Synapses; Synaptic Transmission; Time Factors | 2005 |
Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction.
Topics: Acetylcholinesterase; Aconitine; Animals; Animals, Newborn; Antibodies, Monoclonal; Cholinergic Fibers; Denervation; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Hippocampus; Immunohistochemistry; Immunotoxins; In Vitro Techniques; Long-Term Potentiation; N-Glycosyl Hydrolases; Neural Inhibition; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Propanolamines; Quinoxalines; Rats; Receptors, Nicotinic; Ribosome Inactivating Proteins, Type 1; Saporins; Valine | 2005 |
Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
Topics: Acetylcholine; Analysis of Variance; Animals; Choline; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electrochemistry; Evoked Potentials; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Male; Mecamylamine; Neostigmine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prefrontal Cortex; Pyridines; Pyrrolidines; Quinoxalines; Rats; Sodium Channel Blockers; Tetrodotoxin; Valine | 2008 |
Properties of distinct ventral tegmental area synapses activated via pedunculopontine or ventral tegmental area stimulation in vitro.
Topics: Aconitine; Afferent Pathways; alpha7 Nicotinic Acetylcholine Receptor; Animals; Bicuculline; Dihydro-beta-Erythroidine; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; In Vitro Techniques; Nicotine; Nicotinic Antagonists; Patch-Clamp Techniques; Pedunculopontine Tegmental Nucleus; Picrotoxin; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Nicotinic; Strontium; Synapses; Synaptic Transmission; Ventral Tegmental Area | 2009 |
Synaptic and extrasynaptic factors governing glutamatergic retinal waves.
Topics: Amino Acid Transport Systems, Acidic; Animals; Animals, Newborn; Aspartic Acid; Calcium; Dihydro-beta-Erythroidine; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; N-Methylaspartate; Neural Inhibition; Nicotinic Antagonists; Patch-Clamp Techniques; Pyridazines; Quinoxalines; Retinal Ganglion Cells; Synapses; Synaptic Transmission; Time Factors; Valine; Vesicular Glutamate Transport Protein 1 | 2009 |
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
Topics: Acetylcholine; Alkaloids; Animals; Azocines; Benzazepines; Decamethonium Compounds; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electrophysiology; Gene Expression; Hexamethonium; Humans; Mecamylamine; Mice; Mice, Transgenic; Muscle, Skeletal; Nicotinic Antagonists; Oocytes; Quinolizines; Quinoxalines; Rats; Receptors, Nicotinic; Varenicline; Xenopus laevis | 2010 |
Specific brainstem neurons switch each other into pacemaker mode to drive movement by activating NMDA receptors.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Biological Clocks; Brain Stem; Cadmium Chloride; Dihydro-beta-Erythroidine; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; Glutamic Acid; Glycyrrhetinic Acid; Humans; In Vitro Techniques; Larva; Models, Biological; Movement; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Periodicity; Pyridazines; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Swimming; Xenopus | 2010 |
The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Reinforcement Schedule; Smoking Cessation; Time Factors; Varenicline | 2011 |
Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
Topics: Animals; Benzazepines; Bridged Bicyclo Compounds, Heterocyclic; Cytosine; Data Interpretation, Statistical; Dihydro-beta-Erythroidine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Varenicline | 2011 |
Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain α4 and β2 subunits.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Aconitine; Animals; Biophysics; CA1 Region, Hippocampal; Channelrhodopsins; Cholinergic Fibers; Diagonal Band of Broca; Dihydro-beta-Erythroidine; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Interneurons; Light; Mice; Neural Pathways; Nicotine; Nicotinic Antagonists; Optics and Photonics; Patch-Clamp Techniques; Quinoxalines; Receptors, Nicotinic; Transduction, Genetic; Voltage-Sensitive Dye Imaging | 2011 |
Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
Topics: Analysis of Variance; Animals; Benzazepines; Brain; Cholinergic Agents; Conditioning, Operant; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Hyperkinesis; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Quinoxalines; Radionuclide Imaging; Receptors, Nicotinic; Substance-Related Disorders; Tritium; Varenicline | 2013 |
Layer-specific interference with cholinergic signaling in the prefrontal cortex by smoking concentrations of nicotine.
Topics: Acetylcholine; Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Newborn; Bicuculline; Calcium; Cholinesterase Inhibitors; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Galantamine; In Vitro Techniques; Mice; Mice, Inbred C57BL; Nerve Net; Neurons; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Prefrontal Cortex; Quinoxalines; Receptors, Nicotinic; Signal Transduction | 2013 |
Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Dihydro-beta-Erythroidine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Midazolam; Morphine; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex.
Topics: Animals; Antidepressive Agents; Benzothiadiazines; Dihydro-beta-Erythroidine; Dorsal Raphe Nucleus; Dose-Response Relationship, Drug; Injections, Subcutaneous; Ketamine; Male; Microdialysis; Microinjections; Nicotinic Antagonists; Prefrontal Cortex; Quinoxalines; Rats; Receptors, AMPA; Receptors, Nicotinic; Serotonin; Spermine | 2014 |
Nicotinic activity depresses synaptic potentiation in layer V pyramidal neurons of mouse insular cortex.
Topics: Acetylcholine; Animals; Animals, Newborn; Bicuculline; Cerebral Cortex; Cholinergic Agents; Dihydro-beta-Erythroidine; Excitatory Amino Acid Antagonists; Female; GABA-A Receptor Antagonists; Lysine; Male; Mice; Mice, Inbred C57BL; Neural Inhibition; Nicotine; Pyramidal Cells; Quinoxalines; Synaptic Potentials; Valine | 2017 |